| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 44 | 2023 | 534 | 4.630 |
Why?
|
| Hyaluronic Acid | 23 | 2023 | 97 | 3.950 |
Why?
|
| Proteoglycans | 42 | 2020 | 345 | 3.100 |
Why?
|
| Aggrecans | 27 | 2023 | 155 | 2.820 |
Why?
|
| ADAM Proteins | 13 | 2015 | 65 | 2.320 |
Why?
|
| Extracellular Matrix Proteins | 27 | 2023 | 131 | 2.210 |
Why?
|
| Osteoarthritis | 16 | 2015 | 366 | 2.030 |
Why?
|
| Chondroitin Sulfates | 23 | 2018 | 30 | 1.990 |
Why?
|
| Animals | 82 | 2022 | 4638 | 1.830 |
Why?
|
| Glycosaminoglycans | 23 | 2023 | 53 | 1.610 |
Why?
|
| Fibroblasts | 4 | 2020 | 93 | 1.360 |
Why?
|
| Gene Expression Regulation | 7 | 2020 | 282 | 1.330 |
Why?
|
| Hyaluronan Receptors | 6 | 2012 | 33 | 1.290 |
Why?
|
| Osteoarthritis, Knee | 5 | 2019 | 382 | 1.240 |
Why?
|
| Transforming Growth Factor beta1 | 7 | 2019 | 31 | 1.170 |
Why?
|
| Wound Healing | 7 | 2020 | 168 | 1.040 |
Why?
|
| Versicans | 5 | 2020 | 17 | 1.030 |
Why?
|
| Mice, Inbred C57BL | 14 | 2020 | 435 | 0.950 |
Why?
|
| Horse Diseases | 2 | 2016 | 4 | 0.950 |
Why?
|
| Ligaments | 2 | 2016 | 15 | 0.940 |
Why?
|
| Mice | 20 | 2022 | 1628 | 0.900 |
Why?
|
| Achilles Tendon | 5 | 2019 | 18 | 0.870 |
Why?
|
| Endopeptidases | 6 | 2011 | 30 | 0.850 |
Why?
|
| Chondrocytes | 10 | 2015 | 203 | 0.850 |
Why?
|
| Keratan Sulfate | 9 | 2008 | 27 | 0.810 |
Why?
|
| Viscosupplements | 2 | 2012 | 11 | 0.800 |
Why?
|
| Cartilage | 13 | 2022 | 154 | 0.770 |
Why?
|
| Proteolysis | 2 | 2020 | 13 | 0.760 |
Why?
|
| Stromal Cells | 3 | 2020 | 36 | 0.760 |
Why?
|
| Glucosamine | 4 | 2009 | 9 | 0.750 |
Why?
|
| Cattle | 29 | 2019 | 219 | 0.740 |
Why?
|
| Knee Injuries | 3 | 2017 | 228 | 0.740 |
Why?
|
| Transforming Growth Factor beta | 6 | 2016 | 124 | 0.720 |
Why?
|
| Fibrosis | 6 | 2017 | 38 | 0.670 |
Why?
|
| Dermatan Sulfate | 8 | 2018 | 8 | 0.670 |
Why?
|
| Bone and Bones | 3 | 2017 | 124 | 0.660 |
Why?
|
| Synovial Fluid | 7 | 2011 | 124 | 0.640 |
Why?
|
| Lectins, C-Type | 15 | 2023 | 111 | 0.610 |
Why?
|
| Glucuronosyltransferase | 2 | 2015 | 6 | 0.600 |
Why?
|
| Pyridones | 1 | 2017 | 14 | 0.590 |
Why?
|
| ADAMTS5 Protein | 8 | 2018 | 28 | 0.590 |
Why?
|
| Signal Transduction | 5 | 2018 | 491 | 0.590 |
Why?
|
| Gene Expression | 5 | 2016 | 231 | 0.590 |
Why?
|
| Carrier Proteins | 8 | 2016 | 99 | 0.560 |
Why?
|
| Adipose Tissue | 1 | 2016 | 74 | 0.540 |
Why?
|
| Male | 28 | 2022 | 15851 | 0.530 |
Why?
|
| RNA | 1 | 2015 | 40 | 0.520 |
Why?
|
| Genome, Human | 1 | 2015 | 44 | 0.510 |
Why?
|
| Horses | 7 | 2016 | 19 | 0.510 |
Why?
|
| Tendinopathy | 4 | 2019 | 60 | 0.500 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 80 | 0.500 |
Why?
|
| Synovial Membrane | 4 | 2012 | 79 | 0.480 |
Why?
|
| Cells, Cultured | 16 | 2020 | 682 | 0.470 |
Why?
|
| Hyaluronan Synthases | 4 | 2018 | 8 | 0.460 |
Why?
|
| Alpha-Globulins | 2 | 2011 | 7 | 0.460 |
Why?
|
| Glucose | 3 | 2019 | 60 | 0.450 |
Why?
|
| Joints | 3 | 2009 | 99 | 0.440 |
Why?
|
| Disease Models, Animal | 10 | 2022 | 744 | 0.430 |
Why?
|
| Knee Joint | 5 | 2015 | 800 | 0.430 |
Why?
|
| Electrophoresis | 9 | 2010 | 16 | 0.420 |
Why?
|
| Mice, Knockout | 8 | 2018 | 309 | 0.420 |
Why?
|
| Molecular Sequence Data | 13 | 2009 | 245 | 0.410 |
Why?
|
| Biomechanical Phenomena | 11 | 2019 | 680 | 0.410 |
Why?
|
| Glycoside Hydrolases | 3 | 2001 | 3 | 0.400 |
Why?
|
| Dermis | 1 | 2011 | 6 | 0.390 |
Why?
|
| Sequence Deletion | 1 | 2011 | 13 | 0.390 |
Why?
|
| Connective Tissue Diseases | 1 | 2011 | 9 | 0.380 |
Why?
|
| Gene Silencing | 1 | 2010 | 23 | 0.370 |
Why?
|
| Stifle | 1 | 2010 | 11 | 0.370 |
Why?
|
| Hyperalgesia | 1 | 2011 | 45 | 0.370 |
Why?
|
| Glioma | 1 | 2010 | 52 | 0.360 |
Why?
|
| Humans | 42 | 2020 | 29815 | 0.350 |
Why?
|
| Tissue Engineering | 4 | 2019 | 36 | 0.350 |
Why?
|
| Protein Biosynthesis | 6 | 1996 | 25 | 0.340 |
Why?
|
| Arthritis, Experimental | 1 | 2010 | 130 | 0.340 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 134 | 0.330 |
Why?
|
| Rats | 9 | 2020 | 876 | 0.330 |
Why?
|
| Swine | 1 | 2008 | 83 | 0.320 |
Why?
|
| Growth Plate | 4 | 2008 | 23 | 0.320 |
Why?
|
| Rabbits | 13 | 2009 | 283 | 0.310 |
Why?
|
| Tendons | 2 | 2018 | 223 | 0.300 |
Why?
|
| Immunohistochemistry | 5 | 2012 | 411 | 0.300 |
Why?
|
| Disaccharides | 5 | 2005 | 5 | 0.300 |
Why?
|
| Software | 1 | 2007 | 72 | 0.290 |
Why?
|
| Carbohydrate Sequence | 7 | 2001 | 15 | 0.290 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 6 | 2008 | 29 | 0.280 |
Why?
|
| Chondrogenesis | 3 | 2020 | 30 | 0.270 |
Why?
|
| Stem Cells | 2 | 2020 | 49 | 0.270 |
Why?
|
| Aging | 6 | 2012 | 1630 | 0.270 |
Why?
|
| Inflammation | 2 | 2020 | 347 | 0.270 |
Why?
|
| Models, Biological | 1 | 2007 | 347 | 0.250 |
Why?
|
| beta-Galactosidase | 3 | 2001 | 8 | 0.250 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2016 | 8 | 0.250 |
Why?
|
| Cornea | 2 | 2001 | 7 | 0.250 |
Why?
|
| Acetylglucosaminidase | 2 | 2001 | 5 | 0.240 |
Why?
|
| Arthralgia | 2 | 2019 | 122 | 0.230 |
Why?
|
| Sulfur | 2 | 2003 | 5 | 0.230 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 164 | 0.230 |
Why?
|
| Polyelectrolytes | 1 | 2023 | 2 | 0.220 |
Why?
|
| Chondroitin Lyases | 4 | 1999 | 6 | 0.220 |
Why?
|
| Chromatography, Ion Exchange | 6 | 2001 | 12 | 0.220 |
Why?
|
| Molecular Weight | 3 | 2020 | 44 | 0.210 |
Why?
|
| Extracellular Matrix | 4 | 2015 | 75 | 0.200 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2001 | 1 | 0.200 |
Why?
|
| Biomarkers | 3 | 2020 | 704 | 0.200 |
Why?
|
| Fibromodulin | 8 | 2019 | 15 | 0.200 |
Why?
|
| Hyaluronoglucosaminidase | 2 | 2019 | 4 | 0.190 |
Why?
|
| X-Ray Microtomography | 3 | 2022 | 79 | 0.190 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2020 | 7 | 0.180 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2020 | 23 | 0.180 |
Why?
|
| Administration, Oral | 4 | 2009 | 144 | 0.180 |
Why?
|
| Blotting, Western | 7 | 2011 | 175 | 0.180 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 27 | 0.180 |
Why?
|
| Phagocytosis | 1 | 2020 | 51 | 0.180 |
Why?
|
| Amino Acid Sequence | 7 | 2009 | 195 | 0.180 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 27 | 0.180 |
Why?
|
| Scleroderma, Systemic | 1 | 2020 | 18 | 0.180 |
Why?
|
| Calcinosis | 1 | 2020 | 48 | 0.180 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2000 | 7 | 0.180 |
Why?
|
| Cell Separation | 1 | 2020 | 42 | 0.180 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 129 | 0.180 |
Why?
|
| Fibrillar Collagens | 1 | 2019 | 2 | 0.170 |
Why?
|
| Rotator Cuff | 2 | 2020 | 266 | 0.170 |
Why?
|
| Trisaccharides | 1 | 1999 | 2 | 0.170 |
Why?
|
| Cell Proliferation | 1 | 2020 | 206 | 0.170 |
Why?
|
| Bursitis | 1 | 2019 | 10 | 0.170 |
Why?
|
| Macrophages | 1 | 2020 | 128 | 0.170 |
Why?
|
| Meniscus | 1 | 2019 | 18 | 0.170 |
Why?
|
| Female | 13 | 2017 | 16412 | 0.170 |
Why?
|
| Osteolysis | 1 | 2020 | 138 | 0.170 |
Why?
|
| Phenotype | 1 | 2020 | 362 | 0.170 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 165 | 0.160 |
Why?
|
| Contrast Media | 2 | 2017 | 125 | 0.160 |
Why?
|
| Oligosaccharides | 4 | 2001 | 18 | 0.160 |
Why?
|
| Calcaneus | 1 | 2018 | 7 | 0.160 |
Why?
|
| Bursa, Synovial | 1 | 2018 | 9 | 0.160 |
Why?
|
| Cattle Diseases | 1 | 1998 | 1 | 0.160 |
Why?
|
| Lactic Acid | 1 | 2018 | 17 | 0.160 |
Why?
|
| DNA | 4 | 2015 | 122 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 16 | 0.160 |
Why?
|
| Injections, Intra-Articular | 3 | 2019 | 88 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 181 | 0.150 |
Why?
|
| Chondroitin | 3 | 2010 | 6 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 215 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2001 | 37 | 0.150 |
Why?
|
| Aminopyridines | 1 | 1996 | 3 | 0.140 |
Why?
|
| Chromatin | 1 | 2016 | 14 | 0.140 |
Why?
|
| Time Factors | 8 | 2012 | 1641 | 0.140 |
Why?
|
| Pyrroles | 1 | 2016 | 23 | 0.140 |
Why?
|
| Decorin | 5 | 2019 | 17 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 4 | 2009 | 63 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2016 | 50 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2001 | 35 | 0.130 |
Why?
|
| Chondroitin ABC Lyase | 3 | 2007 | 6 | 0.130 |
Why?
|
| Embryo, Mammalian | 2 | 2008 | 30 | 0.130 |
Why?
|
| Cyclopentanes | 1 | 1995 | 4 | 0.130 |
Why?
|
| Viral Core Proteins | 1 | 1995 | 4 | 0.130 |
Why?
|
| Chronic Disease | 2 | 2015 | 508 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2016 | 127 | 0.130 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2012 | 31 | 0.130 |
Why?
|
| Antigens | 1 | 1995 | 27 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 29 | 0.120 |
Why?
|
| Amino Sugars | 1 | 1993 | 1 | 0.120 |
Why?
|
| Polysaccharides | 1 | 1993 | 15 | 0.120 |
Why?
|
| Macromolecular Substances | 7 | 2005 | 17 | 0.110 |
Why?
|
| Cell Aggregation | 2 | 2011 | 2 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 270 | 0.110 |
Why?
|
| Histological Techniques | 1 | 1993 | 6 | 0.110 |
Why?
|
| Kinetics | 7 | 2008 | 230 | 0.110 |
Why?
|
| Bone Marrow Cells | 2 | 2010 | 58 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 1998 | 149 | 0.110 |
Why?
|
| Aged | 8 | 2007 | 9620 | 0.110 |
Why?
|
| Heparin | 2 | 2010 | 27 | 0.100 |
Why?
|
| Injections, Intra-Arterial | 1 | 2012 | 8 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 456 | 0.100 |
Why?
|
| Running | 1 | 2012 | 13 | 0.100 |
Why?
|
| Physical Conditioning, Animal | 2 | 2013 | 7 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2008 | 97 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 57 | 0.100 |
Why?
|
| Fibril-Associated Collagens | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 273 | 0.100 |
Why?
|
| Transcriptome | 1 | 2012 | 84 | 0.100 |
Why?
|
| Exercise Therapy | 1 | 2012 | 112 | 0.100 |
Why?
|
| Activin Receptors | 1 | 2011 | 1 | 0.100 |
Why?
|
| Epithelioid Cells | 1 | 2011 | 1 | 0.100 |
Why?
|
| Smad Proteins, Receptor-Regulated | 1 | 2011 | 1 | 0.100 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2011 | 9 | 0.100 |
Why?
|
| Activin Receptors, Type II | 1 | 2011 | 2 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 3 | 0.100 |
Why?
|
| Organ Size | 1 | 2011 | 107 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2011 | 58 | 0.100 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 44 | 0.090 |
Why?
|
| Collagen | 3 | 2018 | 102 | 0.090 |
Why?
|
| Heparitin Sulfate | 3 | 2010 | 6 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2011 | 159 | 0.090 |
Why?
|
| Middle Aged | 8 | 2011 | 9960 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 58 | 0.090 |
Why?
|
| Sulfates | 6 | 2006 | 16 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2010 | 202 | 0.090 |
Why?
|
| Genotype | 1 | 2011 | 399 | 0.090 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2009 | 6 | 0.090 |
Why?
|
| Dogs | 2 | 2009 | 261 | 0.090 |
Why?
|
| Hydrolysis | 2 | 2001 | 10 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2011 | 291 | 0.080 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 4 | 2016 | 6 | 0.080 |
Why?
|
| Adolescent | 3 | 2001 | 2332 | 0.080 |
Why?
|
| Recombinant Proteins | 4 | 2019 | 258 | 0.080 |
Why?
|
| Disulfides | 1 | 2009 | 12 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2009 | 18 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2009 | 109 | 0.080 |
Why?
|
| Isomerism | 2 | 1999 | 3 | 0.080 |
Why?
|
| Joint Capsule | 1 | 2009 | 43 | 0.080 |
Why?
|
| Apoptosis | 1 | 2010 | 259 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2007 | 218 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2008 | 7 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2008 | 22 | 0.080 |
Why?
|
| Fluorescent Dyes | 2 | 2001 | 55 | 0.080 |
Why?
|
| Stress, Mechanical | 5 | 2010 | 169 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2008 | 4 | 0.080 |
Why?
|
| Immune System | 1 | 2008 | 22 | 0.080 |
Why?
|
| RANK Ligand | 1 | 2008 | 7 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 223 | 0.080 |
Why?
|
| Osteoclasts | 1 | 2008 | 21 | 0.080 |
Why?
|
| Fucose | 2 | 2001 | 2 | 0.080 |
Why?
|
| Chromatography, Gel | 4 | 2010 | 15 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 204 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 221 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 40 | 0.080 |
Why?
|
| Bone Remodeling | 1 | 2008 | 44 | 0.080 |
Why?
|
| Osteoblasts | 1 | 2008 | 63 | 0.080 |
Why?
|
| Molecular Structure | 3 | 2003 | 28 | 0.080 |
Why?
|
| Microscopy, Atomic Force | 4 | 2010 | 8 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 2 | 2006 | 22 | 0.070 |
Why?
|
| Systems Biology | 1 | 2007 | 7 | 0.070 |
Why?
|
| Cryptococcus neoformans | 1 | 2007 | 1 | 0.070 |
Why?
|
| Glycosyltransferases | 1 | 2007 | 1 | 0.070 |
Why?
|
| Surface-Active Agents | 1 | 2007 | 6 | 0.070 |
Why?
|
| Body Temperature | 1 | 2007 | 59 | 0.070 |
Why?
|
| Gait | 1 | 2011 | 406 | 0.070 |
Why?
|
| Membrane Glycoproteins | 2 | 2006 | 102 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 116 | 0.070 |
Why?
|
| Proteins | 2 | 1991 | 71 | 0.070 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2006 | 3 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Adult | 7 | 2011 | 8741 | 0.070 |
Why?
|
| Alkalies | 1 | 1986 | 3 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 69 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2006 | 53 | 0.070 |
Why?
|
| Sulfur Radioisotopes | 4 | 1996 | 13 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 101 | 0.070 |
Why?
|
| Pain | 1 | 2009 | 397 | 0.070 |
Why?
|
| Culture Techniques | 5 | 1997 | 24 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2006 | 65 | 0.070 |
Why?
|
| Nanostructures | 1 | 2005 | 13 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 43 | 0.060 |
Why?
|
| Biglycan | 3 | 2000 | 17 | 0.060 |
Why?
|
| Ioxaglic Acid | 2 | 2017 | 5 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 30 | 0.060 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2005 | 11 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 58 | 0.060 |
Why?
|
| Tritium | 3 | 1996 | 14 | 0.060 |
Why?
|
| Algorithms | 1 | 2007 | 400 | 0.060 |
Why?
|
| Organ Culture Techniques | 3 | 1996 | 29 | 0.060 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2003 | 3 | 0.060 |
Why?
|
| Epitopes | 3 | 2009 | 88 | 0.060 |
Why?
|
| Protein Binding | 4 | 2003 | 125 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2003 | 25 | 0.060 |
Why?
|
| Sulfotransferases | 2 | 2003 | 6 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 3 | 1989 | 13 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2003 | 71 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2003 | 106 | 0.060 |
Why?
|
| Leucine | 2 | 1996 | 15 | 0.050 |
Why?
|
| Chromatography | 2 | 1995 | 3 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2001 | 654 | 0.050 |
Why?
|
| Chondrosarcoma | 2 | 1999 | 33 | 0.050 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 2 | 0.050 |
Why?
|
| Fetus | 2 | 2000 | 56 | 0.050 |
Why?
|
| Acetylglucosamine | 1 | 2001 | 2 | 0.050 |
Why?
|
| Glycopeptides | 1 | 2001 | 5 | 0.050 |
Why?
|
| Tail | 1 | 2001 | 4 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 28 | 0.050 |
Why?
|
| P-Selectin | 1 | 2000 | 3 | 0.050 |
Why?
|
| L-Selectin | 1 | 2000 | 17 | 0.050 |
Why?
|
| Reference Values | 2 | 1998 | 230 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 21 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 56 | 0.040 |
Why?
|
| Age Factors | 2 | 1997 | 853 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 40 | 0.040 |
Why?
|
| Skin | 1 | 2000 | 118 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 22 | 0.040 |
Why?
|
| Injections | 1 | 2019 | 59 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 28 | 0.040 |
Why?
|
| Regeneration | 1 | 2019 | 27 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2011 | 364 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 230 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 159 | 0.040 |
Why?
|
| Rotator Cuff Injuries | 2 | 2020 | 280 | 0.040 |
Why?
|
| Ligaments, Articular | 1 | 2000 | 104 | 0.040 |
Why?
|
| Binding Sites | 2 | 2006 | 76 | 0.040 |
Why?
|
| Small Leucine-Rich Proteoglycans | 1 | 2018 | 1 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2018 | 1 | 0.040 |
Why?
|
| Electrophoresis, Capillary | 1 | 1998 | 1 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 1996 | 54 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 355 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1998 | 12 | 0.040 |
Why?
|
| Biological Transport | 2 | 1995 | 44 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 13 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 21 | 0.040 |
Why?
|
| Glycolysis | 1 | 2018 | 21 | 0.040 |
Why?
|
| Nanotechnology | 2 | 2010 | 12 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 1998 | 8 | 0.040 |
Why?
|
| Weight-Bearing | 2 | 2012 | 168 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2005 | 70 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 143 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 55 | 0.040 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 1997 | 9 | 0.040 |
Why?
|
| Tretinoin | 1 | 1997 | 15 | 0.040 |
Why?
|
| Trypsin | 1 | 2017 | 6 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 1997 | 79 | 0.040 |
Why?
|
| Immunoassay | 1 | 1997 | 42 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 34 | 0.040 |
Why?
|
| Glycoproteins | 1 | 1997 | 57 | 0.040 |
Why?
|
| Monosaccharides | 1 | 1996 | 2 | 0.040 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 2 | 2010 | 6 | 0.040 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 3 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 26 | 0.030 |
Why?
|
| Brain | 1 | 2006 | 1726 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 19 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1996 | 10 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 81 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 53 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 3561 | 0.030 |
Why?
|
| Infant | 1 | 1997 | 542 | 0.030 |
Why?
|
| Cell Line | 2 | 2008 | 299 | 0.030 |
Why?
|
| ADAMTS4 Protein | 2 | 2007 | 18 | 0.030 |
Why?
|
| Procollagen N-Endopeptidase | 2 | 2007 | 16 | 0.030 |
Why?
|
| Brefeldin A | 1 | 1995 | 3 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 1995 | 4 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 11 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 7 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2015 | 7 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2015 | 10 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 298 | 0.030 |
Why?
|
| Syndecans | 2 | 2006 | 2 | 0.030 |
Why?
|
| Syndecan-1 | 2 | 2006 | 8 | 0.030 |
Why?
|
| Ribs | 1 | 1995 | 16 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 33 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 132 | 0.030 |
Why?
|
| Mannosidases | 1 | 1993 | 1 | 0.030 |
Why?
|
| alpha-Mannosidase | 1 | 1993 | 1 | 0.030 |
Why?
|
| Hydroxyproline | 2 | 2010 | 6 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2013 | 13 | 0.030 |
Why?
|
| Integrins | 1 | 2013 | 20 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 20 | 0.030 |
Why?
|
| In Vitro Techniques | 3 | 2003 | 215 | 0.030 |
Why?
|
| Tibia | 1 | 1995 | 266 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2006 | 324 | 0.030 |
Why?
|
| Hindlimb | 1 | 2012 | 25 | 0.030 |
Why?
|
| Transfection | 2 | 2003 | 130 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 2010 | 5 | 0.020 |
Why?
|
| Tunicamycin | 1 | 1990 | 2 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1990 | 6 | 0.020 |
Why?
|
| Amino Acids | 1 | 1990 | 21 | 0.020 |
Why?
|
| Glycosylation | 1 | 1990 | 24 | 0.020 |
Why?
|
| Models, Molecular | 1 | 1990 | 82 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 128 | 0.020 |
Why?
|
| Hydrogels | 1 | 2010 | 9 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1989 | 9 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2009 | 82 | 0.020 |
Why?
|
| Ankle Injuries | 1 | 2009 | 12 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 10 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 165 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2009 | 11 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 36 | 0.020 |
Why?
|
| Streptomyces | 1 | 1989 | 1 | 0.020 |
Why?
|
| Silver Staining | 1 | 2009 | 5 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 41 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 245 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 66 | 0.020 |
Why?
|
| Femur | 1 | 2012 | 393 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 3 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 10 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 32 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 98 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 46 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 155 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 337 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2008 | 95 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 256 | 0.020 |
Why?
|
| Proline | 3 | 1994 | 19 | 0.020 |
Why?
|
| Escherichia | 1 | 2007 | 1 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2007 | 7 | 0.020 |
Why?
|
| Biological Assay | 1 | 2007 | 9 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 103 | 0.020 |
Why?
|
| Virulence | 1 | 2007 | 15 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 7 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2007 | 18 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2007 | 5 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2007 | 13 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 8 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2009 | 468 | 0.020 |
Why?
|
| Liposomes | 1 | 2007 | 13 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2007 | 4 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2007 | 11 | 0.020 |
Why?
|
| Cats | 1 | 2007 | 75 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2007 | 14 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2007 | 112 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 84 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2006 | 15 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2006 | 8 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2006 | 27 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2007 | 103 | 0.020 |
Why?
|
| Microcirculation | 1 | 2006 | 39 | 0.020 |
Why?
|
| Arthritis | 1 | 2007 | 106 | 0.020 |
Why?
|
| Methylene Blue | 1 | 1986 | 2 | 0.020 |
Why?
|
| Half-Life | 1 | 1986 | 18 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 1985 | 2 | 0.020 |
Why?
|
| Methods | 1 | 1985 | 17 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1985 | 23 | 0.020 |
Why?
|
| Bone Density | 1 | 2007 | 151 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 74 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2011 | 1823 | 0.020 |
Why?
|
| Elasticity | 1 | 2005 | 40 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2005 | 33 | 0.020 |
Why?
|
| Static Electricity | 1 | 2005 | 45 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 45 | 0.020 |
Why?
|
| DNA Primers | 1 | 2005 | 54 | 0.020 |
Why?
|
| Base Sequence | 1 | 2005 | 133 | 0.020 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2007 | 276 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 105 | 0.020 |
Why?
|
| Cell Division | 1 | 1984 | 112 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2003 | 1 | 0.010 |
Why?
|
| Endopeptidase K | 1 | 2003 | 5 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 12 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 9 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 19 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 9 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 69 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 1966 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 91 | 0.010 |
Why?
|
| Hydrostatic Pressure | 2 | 1994 | 3 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 397 | 0.010 |
Why?
|
| Biotinylation | 1 | 2000 | 2 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 28 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 17 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2000 | 31 | 0.010 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2000 | 1 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 149 | 0.010 |
Why?
|
| Cicatrix | 1 | 2000 | 12 | 0.010 |
Why?
|
| Pressure | 2 | 1991 | 61 | 0.010 |
Why?
|
| Gestational Age | 1 | 2000 | 75 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2000 | 112 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2000 | 173 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 558 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 463 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 1997 | 6 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1997 | 5 | 0.010 |
Why?
|
| Dipeptides | 1 | 1997 | 4 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 1997 | 14 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1997 | 134 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1995 | 14 | 0.010 |
Why?
|
| Gap Junctions | 1 | 1995 | 12 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 73 | 0.010 |
Why?
|
| Autoradiography | 1 | 1994 | 11 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 1994 | 12 | 0.010 |
Why?
|
| Diffusion | 1 | 1994 | 28 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1994 | 84 | 0.010 |
Why?
|
| Menisci, Tibial | 1 | 1995 | 172 | 0.010 |
Why?
|
| RNA, Transfer, Pro | 1 | 1989 | 1 | 0.010 |
Why?
|
| Hexuronic Acids | 1 | 1984 | 10 | 0.000 |
Why?
|